Stay updated on IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Sign up to get notified when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.

Latest updates to the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference12%

- Check26 days agoChange DetectedVersion updated from v3.0.2 (Deletions) to v3.1.0 (Additions).SummaryDifference0.3%

- Check40 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1. The Back to Top link has been removed.SummaryDifference0.7%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%

- Check55 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference8%

- Check69 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.